This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Five Prime Therapeutics, Inc., Ucbbiopharma Srl. Active years: 2024.
Company Filing History:
1 out of 77 
1 out of 129 Years Active: 2024
Title: The Innovative Contributions of Danielle E Kellar
Introduction
Danielle E Kellar is a notable inventor based in San Francisco, CA. She has made significant strides in the field of medical research, particularly in the treatment of fibrosis. Her work has the potential to impact various therapeutic approaches in medicine.
Latest Patents
Danielle holds a patent for the "Medical use of interferon-lambda for the treatment of fibrosis." This invention relates to methods for treating fibrosis and reveals new research demonstrating that interferon-lambda has direct anti-fibrotic effects both in vitro and in vivo. This discovery may lead to effective new therapies for multiple types of fibrosis.
Career Highlights
Throughout her career, Danielle has worked with prominent companies such as UCB Biopharma and Five Prime Therapeutics, Inc. Her experience in these organizations has contributed to her expertise and innovative capabilities in the medical field.
Collaborations
Danielle has collaborated with notable professionals, including Timothy Scott Johnson and Breda Twomey. These partnerships have likely enriched her research and development efforts.
Conclusion
Danielle E Kellar's contributions to the field of fibrosis treatment through her innovative patent highlight her role as a leading inventor in medical research. Her work continues to pave the way for new therapeutic options in healthcare.